Who is sponsoring NCT07065604?

NCT07065604 is sponsored by Shuben Li.

What drugs are being tested in NCT07065604?

Interventions in NCT07065604: Non-intubated VATS for mediastinal neoplasm, Intubated VATS for mediastinal neoplasm.

What condition does NCT07065604 study?

NCT07065604 studies Mediastinal Neoplasm, VATS, Tubeless, Non-intubated Anesthesia.

Is NCT07065604 still recruiting?

NCT07065604 is currently recruiting now. Last updated 15 July 2025.

Last reviewed 2025-07-15 · How we verify

NCT07065604: NOVA-02

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tubeless VATS for Mediastinal Neoplasm

Recruiting now NA Last updated 15 July 2025

What this trial tests

NA trial testing Non-intubated VATS for mediastinal neoplasm in Mediastinal Neoplasm in 132 participants. Currently enrolling.

Timeline

26 March 2025

Primary endpoint
1 May 2028

31 August 2028

Quick facts

Lead sponsor	Shuben Li
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	132
Start date	26 March 2025
Primary completion	1 May 2028
Estimated completion	31 August 2028
Sites	1 location across China

Drugs / interventions tested

Non-intubated VATS for mediastinal neoplasm
Intubated VATS for mediastinal neoplasm

Conditions studied

Mediastinal Neoplasm — all drugs for Mediastinal Neoplasm →
VATS — all drugs for VATS →
Tubeless — all drugs for Tubeless →
Non-intubated Anesthesia — all drugs for Non-intubated Anesthesia →

Sponsor

Shuben Li

Who can join

Adults 18 to 80, any sex, with Mediastinal Neoplasm or VATS. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In recent year, non-intubated anesthesia had emerged as an available and promising alternative for thoracic procedure. However, its safety and feasibility in video-assisted thoracoscopic surgery (VATS) for mediastinal neoplasm remain controversial. This randomized controlled trial is designed to evaluate the impact of the non-intubated approach on surgical and perioperative outcomes in patients undergoing mediastinal neoplasm resection.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mediastinal Neoplasm

Currently open trials in the same condition.

NCT05672108 — Phase II Trial of Lung Chemoemobolization · Phase 2 · recruiting

Other Shuben Li trials

Trials by the same sponsor.

NCT07065565 — Tubeless Tracheal and Carinal Reconstruction · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07065604 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shuben Li
Last refreshed: 15 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07065604.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing